It was a shock to learn today that New York Stem Cell Foundation CEO and Co-Founder Susan Solomon had passed away yesterday after a long battle with ovarian cancer. I met Susan a few times over the years and was always struck by her positive energy. At a practical level she got big things done […]
Tributes to NYSCF leader & stem cell advocate Susan Solomon Read More »
Over the past dozen years as I’ve written about stem cell clinics here on The Niche I’ve gotten to know many of those running the clinics including Dr. Mark Berman of Beverly Hills. It was therefore kind of a shock to learn that Berman died of last month. Michael Hiltzik of the LA Times reported
Thoughts on death of stem cell clinic leader Dr. Mark Berman Read More »
One of the most interesting parts of running a website like The Niche is that reader’s questions can sometimes be so striking including recent ones on human cloning. They got me thinking about cloning again. Human cloning & loss of a loved one: things to consider Several readers have recently asked about whether human cloning
If you lost a loved one, could you turn to human cloning? Read More »
Great ideas and talented scientists are not enough as biomedical research needs funding and here in the U.S. that means having R01 grant success. The trends since 1995 are slowly heading the wrong way. The average age of getting your first R01 grant keeps getting older. There is also still a bit of a possible
Weekly reads: R01 grant trends, DPPA4, adult human neurogenesis debate Read More »
The push for de-extinction of woolly mammoths is a perfect example of when one notion can be both fun and a rotten idea. You can’t let the coolness push you down a bad path. You can see my new YouTube video covering the main points of this post from our YouTube channel further down. Please
Why De-extinction of Woolly Mammoths is Still a Bad Idea Read More »
The Niche has had many authors over the years, focusing on expertise in the biomedical arena and in particular related to stem cells. I’ve invited many authorities in particular areas to write posts. Over the years I’ve written probably 99+% of the posts here on The Niche, but we’ve also had some great guest authors
Authors on The Niche Read More »
The unproven stem cell clinic firm US Stem Cell Inc. is in a world of hurt. If a federal judge says you can no longer sell your key commercial offering, how do you survive as a company? US Stem probably has been thinking about that possibility for months. Still, it’s not yet clear where the
Can clinic biz US Stem reboot after losing suit? Its email to customers & more Read More »
In a precedent-setting decision, a federal court has ruled for the FDA against a key stem cell clinic firm called U.S. Stem Cell, Inc. The court granted summary judgment for the FDA in its suit seeking a permanent injunction against the Florida stem cell clinic firm. While the company is likely going to appeal, this is
Groundbreaking defeat for US Stem Cell, fat stem cell clinic industry in federal court Read More »
When I read about a stem cell penis growth injection, what comes to mind first when you read that is “Ow!” The goal of today’s post is to fact-check this whole area. What’s in this article Stem cell penis growth | Risks |US Stem Cell Clinic claims |Does it work? | Does size matter? | Data check
Stem cell penile growth fact check Read More »
Could the blinding of three women at a stem cell clinic have been prevented by better oversight or was the clinic acting outside of the scope of oversight by its institutional review board (IRB)? More broadly, when is an IRB conducting proper oversight and how do we know? When on the other hand is it
Does stem cell clinic IRB approval mean much? Insights from blinding cases Read More »